US Patent Issued to Amgen on Oct. 21 for "Methods of using heterocyclic compounds as Delta-5 Desaturase inhibitors" (Italian, American Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,396, issued on Oct. 21, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Methods of using heterocyclic compounds as Delta-5 Desaturase inhibitors" was invented by Jennifer R. Allen (Newbury Park, Calif.), Michela Beltrani (Verona, Italy), Matthew P. Bourbeau (Woodland Hills, Calif.), Teodora P. Damyanova (Verona, Italy), Iain Lingard (Verona, Italy), Ana E. Minatti (Los Angeles) and Paolo Vincetti (Verona, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds useful for the inhibition of Delta-5 Desaturase ("D5D"). The compounds have a general Formula I.wherein the variables of Formula I are defined herei...